European Commission/EMA meeting with stakeholders on Translarna (ataluren)
EventHumanMedicines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Date
Location
EMA and the European Commission are organising a meeting with patients, healthcare professionals and their organisations.
The meeting aims to provide an overview of the evaluation process, the evidence considered, the stakeholder involvement and the scientific grounds for EMA's recommendation on Translarna.
There will also be an opportunity for patients, their caregivers and healthcare professionals to raise questions.
Registration by invitation only.